Relmada Therapeutics, Inc.盘中异动早盘快速下挫5.87%报0.442美元

市场透视12-11

北京时间2024年12月11日22时31分，Relmada Therapeutics, Inc.（RLMD.us）股票出现波动，股价大幅下跌5.87%。截至发稿，该股报0.442美元/股，成交量6.6861万股，换手率0.22%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.73百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2490868978?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-11 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2490868978","market":"us","top_or_hot":-1,"title":"Relmada Therapeutics, Inc.盘中异动 早盘快速下挫5.87%报0.442美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月11日22时31分，Relmada Therapeutics, Inc.（RLMD.us）股票出现波动，股价大幅下跌5.87%。截至发稿，该股报0.442美元/股，成交量6.6861万股，换手率0.22%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.73百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relmada Therapeutics, Inc.盘中异动 早盘快速下挫5.87%报0.442美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelmada Therapeutics, Inc.盘中异动 早盘快速下挫5.87%报0.442美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-11 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月11日22时31分，Relmada Therapeutics, Inc.（RLMD.us）股票出现波动，股价大幅下跌5.87%。截至发稿，该股报0.442美元/股，成交量6.6861万股，换手率0.22%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.73百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b","article_id":"2490868978","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2490868978","pubTimestamp":1733927461,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月11日22时31分，Relmada Therapeutics, Inc.股票出现波动，股价大幅下跌5.87%。截至发稿，该股报0.442美元/股，成交量6.6861万股，换手率0.22%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Synlogic, Inc.涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为365.60%、100.62%、97.27%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Synlogic, Inc.、Bioline Rx Ltd，振幅分别为7.69%、6.21%、5.03%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","RLMD":"Relmada Therapeutics, Inc.","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Relmada Therapeutics, Inc. fell 5.87% to $0.442 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"RLMD":1},"content_text":"北京时间2024年12月11日22时31分，Relmada Therapeutics, Inc.（RLMD.us）股票出现波动，股价大幅下跌5.87%。截至发稿，该股报0.442美元/股，成交量6.6861万股，换手率0.22%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.73百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Synlogic, Inc.涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为365.60%、100.62%、97.27%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Synlogic, Inc.、Bioline Rx Ltd，振幅分别为7.69%、6.21%、5.03%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。该公司从事开发化学实体的新型药物产品，以解决中枢神经系统疾病治疗方面未得到满足的高度医疗需求。该公司专注于开发esmethadone（d-美沙酮，dextromethadone，REL-1017），一种N-甲基-D-天门冬氨酸（NMDA）受体拮抗剂。其主要候选产品艾司美沙酮是一种用于治疗抑郁症和其他潜在适应症的口服药剂。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490868978"}

Relmada Therapeutics, Inc.盘中异动 早盘快速下挫5.87%报0.442美元

精彩评论

Relmada Therapeutics, Inc.盘中异动早盘快速下挫5.87%报0.442美元